All Journals

Dedicated to original research that translates fundamental science into practical impact. As a multidisciplinary applied sciences journal, JOAS publishes work spanning applied physics, applied chemistry, materials and nanoscience, applied biology and life sciences, environmental and ecological science, and applied data and social science. The journal exists to connect investigators, engineers, and practitioners worldwide through a trusted and openly citable platform. JOAS welcomes original research articles, critical reviews, case reports, methodological notes, and editorials. Topics of interest include nanomaterials and energy materials such as dye-sensitised solar cells and polymer electrolytes; proteomics, immunomodulation, and biomarker studies; biodiversity, coral-reef health, soil and root-system science; instrumentation and measurement methods including SEM-EDX, X-ray diffraction, and neutron-activation standardisation; food authentication and aroma science; and applied statistical analysis of socio-economic problems such as multidimensional poverty. Every manuscript undergoes rigorous double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence, with authors retaining copyright, and are assigned a permanent Crossref DOI. Content is discoverable through OpenAlex and Google Scholar and exposed for harvesting via an OAI-PMH endpoint. JOAS follows COPE ethical principles and offers article-processing-charge waivers and discounts to widen participation, particularly for early-career and lower-income-country authors.

Serves pathologists, laboratory scientists, clinical chemists, microbiologists and translational researchers seeking a rigorous, discoverable venue for diagnostic work that informs patient care. The journal covers the diagnostic spectrum: histopathology and surgical pathology, cytopathology and fine-needle aspiration cytology, immunohistochemistry (markers such as Her2/neu), haematopathology, clinical chemistry and biomarker studies (HbA1c, ferritin, D-dimer), and molecular and infectious-disease diagnostics using qPCR and FFPE methods. We welcome original research, reviews, diagnostic case reports, method-validation studies and editorials. Every submission undergoes double-blind peer review following COPE principles. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence, authors retain copyright, and each receives a permanent Crossref DOI, discoverable through OpenAlex and Google Scholar and exposed via OAI-PMH.

Advances translational, molecular, and clinical biomedical research. Spanning the full breadth of the biomedical sciences, the journal connects laboratory discovery with patient-centred application across investigators, clinicians, and educators worldwide. The journal welcomes original research, reviews, case reports, and editorials in molecular and cellular biomedicine (including noncoding RNA, tRNA- and snoRNA-derived fragments, RNA processing, and sirtuins), cardiovascular biomedicine (cardiac remodeling, myocardial infarction, and coronary artery disease), immunology and autoimmune disease (Th17/Treg balance, systemic sclerosis, and immunomodulation), drug delivery and nanomedicine (biomimetic and nanoparticle-based therapies), and pharmacology and therapeutics. Methodological, translational, and public-health dimensions of these fields are all in scope. Every submission undergoes rigorous double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence, with authors retaining copyright, and are assigned a permanent Crossref DOI to ensure citability and long-term preservation. Content is discoverable through OpenAlex, Google Scholar, and an OAI-PMH endpoint for harvesting, and the journal follows COPE ethical principles. An article-processing charge applies on acceptance, with waivers and discounts available to support equitable participation.

Advances scholarship that bridges laboratory, clinic, and population health, publishing rigorous work in clinical pharmacology, pharmacotherapy, drug safety, and the pharmaceutical sciences for researchers, clinicians, pharmacists, regulators, and educators worldwide. The journal welcomes original research, systematic reviews, case reports, and editorials across pharmacokinetics and pharmacodynamics, cardiovascular pharmacology, pharmacovigilance and adverse drug reactions, medicinal chemistry and drug development, pharmaceutics and formulation, medicine quality assurance, therapeutic drug monitoring, and neuropsychopharmacology. We particularly encourage translational and real-world evidence studies, including guideline-directed therapy, antiplatelet and heart-failure pharmacotherapy, rational drug use, and medicine-quality research relevant to low- and middle-income settings. Every submission undergoes double-blind peer review in line with COPE principles. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence, with authors retaining copyright, and are assigned a permanent Crossref DOI. All content is discoverable through OpenAlex and Google Scholar and exposed via an OAI-PMH endpoint to maximise citability, reuse, and long-term preservation of the scholarly record.

Advances the science of how chemical, physical, and biological agents harm living systems, spanning organ and systemic toxicology (hepatotoxicity, nephrotoxicity, reproductive and developmental toxicity), environmental toxicology and ecotoxicology, regulatory and pharmaceutical toxicology, and the quantitative methods that underpin them. The journal welcomes original research, reviews, case reports, and methodological studies on dose-response and benchmark-dose modeling, permitted daily exposure and residual-solvent limits, occupational exposure limit derivation, cleaning-validation and shared-facility risk, in vitro and in vivo testing, heavy-metal and pesticide contamination, and natural-product or antioxidant protection against toxic injury. Work integrating histopathology, biomarkers, dosimetry, and Bayesian or Monte Carlo analysis is especially encouraged. JOTR serves toxicologists, pharmacologists, environmental and occupational health scientists, regulatory and risk-assessment professionals, and graduate researchers. Every accepted manuscript undergoes double-blind peer review. All articles are published open access under a Creative Commons Attribution (CC-BY 4.0) license with authors retaining copyright, receive a permanent Crossref DOI, and are made discoverable through OpenAlex, Google Scholar, and an OAI-PMH endpoint, in line with COPE ethical principles.

Dedicated to clinical, surgical, radiologic, developmental, and molecular anatomy. The journal advances understanding of human and comparative structure as it applies to research, medical education, and clinical practice, serving anatomists, surgeons, radiologists, clinicians, and basic scientists worldwide. We publish original research, systematic and narrative reviews, case reports, technical notes, and editorials spanning gross and topographic anatomy, anatomical variations, cadaveric and imaging (MRI, CT, ultrasound) studies, embryology and developmental anatomy, neuroanatomy, cardiac and visceral morphology, and signaling pathways that shape form. Work documenting rare anatomical coexistences, surgical landmarks, and variation-related clinical syndromes is especially welcome. Every submission undergoes rigorous double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence, with authors retaining copyright, and each receives a permanent Crossref DOI. Content is discoverable through OpenAlex and Google Scholar, exposed via our OAI-PMH endpoint, and the journal follows COPE ethical principles. An article-processing charge applies on acceptance, with waivers and discounts available.

Dedicated to the structure, function, variation, and evolution of DNA across all domains of life. The journal serves as an interdisciplinary forum spanning molecular genetics, genomics, cytogenetics, chromosome biology, and DNA-based methodology, connecting laboratory scientists, clinical geneticists, bioinformaticians, and synthetic biologists on a single, internationally accessible platform. We welcome original research, reviews, case reports, and methodological articles on genome structure and organization, gene expression and regulation, comparative and evolutionary genomics, DNA sequencing and PCR-based analysis, karyotyping and molecular cytogenetic techniques, meiosis and mitosis, chromosome condensation, and chromosomal disorders such as microdeletions. Studies on synthetic biology DNA assembly (BioBrick, Golden Gate, iGEM), ribosomal DNA, and comparative cytogenetics in human, animal, and avian systems are equally within scope. Manuscripts undergo rigorous double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence, with authors retaining copyright, and each receives a permanent Crossref DOI. Content is discoverable through OpenAlex and Google Scholar and exposed via an OAI-PMH endpoint for harvesting. The journal follows COPE ethical principles and supports the integrity, citability, and long-term preservation of the DNA and genomics research record. Article-processing charges apply on acceptance, with waivers and discounts available.

Dedicated to research on the molecular machinery of life. It publishes original work on gene expression and regulation, DNA replication and repair, RNA biology, and protein structure and function. We welcome original research articles, reviews, methods papers, case reports, and editorials spanning molecular genetics, transcription and translation, epigenetics, non-coding RNA, and the molecular basis of disease. Studies using genome editing, sequencing, and computational structure prediction are encouraged. Intended for molecular biologists, geneticists, biochemists, and translational researchers, the journal emphasizes rigor, reproducibility, and mechanistic insight, and every submission undergoes double-blind peer review. Accepted articles are published open access under CC-BY 4.0, with authors retaining copyright, and each receives a permanent Crossref DOI. Content is discoverable via OpenAlex and Google Scholar and exposed through OAI-PMH; the journal follows COPE principles.

Dedicated to the science of next-generation treatment. As an advanced therapeutics journal, JOAT publishes original research, reviews, and case reports that move discovery toward the clinic across gene therapy, genome editing, cellular and immune therapies, and precision medicine. The journal welcomes work on CRISPR-Cas9 and homology-directed repair, chimeric antigen receptor (CAR-T) and adoptive cell therapy, complement-targeted and anticomplement treatment, and translational drug development. We also cover cardiac electrophysiology therapeutics such as pulsed field and catheter ablation, hematologic and rare-disease therapeutics, biomarker-guided precision approaches, and the bioethics of germline and emerging interventions. JOAT serves clinician-scientists, translational researchers, immunologists, geneticists, pharmacologists, and bioethicists seeking a rigorous, internationally accessible venue. Submissions span theoretical, methodological, translational, and applied dimensions of advanced therapeutics. Every manuscript undergoes double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence with authors retaining copyright, are assigned a permanent Crossref DOI, and are made discoverable through OpenAlex, Google Scholar, and an OAI-PMH endpoint. The journal follows COPE ethical principles.

Advances the molecular understanding of life through rigorous biochemical research. The journal spans clinical and medical biochemistry, molecular biochemistry, enzymology and metabolism, oxidative stress and antioxidant biology, and computational and applied biochemistry, serving researchers, clinical laboratory scientists, educators, and graduate students worldwide. We welcome original research, reviews, mini-reviews, case reports, and methodological studies on protein structure and function, enzyme kinetics, signal transduction, metabolic pathways, serum biomarkers and electrolytes, lipid and glucose metabolism, inflammatory and diagnostic markers such as C-reactive protein and cardiac enzymes, reactive oxygen species and antioxidant defense, and in silico approaches to bioactive compounds and drug discovery. Plant, nutritional, and applied biochemistry, including salinity-stress and functional-food research, are also within scope. Every submission undergoes double-blind peer review in line with COPE ethical principles. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence with authors retaining copyright, and each receives a permanent Crossref DOI. Content is discoverable through OpenAlex and Google Scholar and exposed via an OAI-PMH endpoint for harvesting, ensuring lasting citability and global reach.

We welcome original research, reviews, case reports, and short communications on topics such as the microbiome and human disease, resistance in Escherichia coli, Klebsiella and Pseudomonas, organoid disease models, stem cell biology, thalassemia and hemoglobin genetics, population dynamics, and biodiversity conservation, using molecular, genomic, ecological, and experimental methods. The journal serves biologists, microbiologists, geneticists, ecologists, clinicians, and graduate researchers seeking a rigorous, multidisciplinary venue. Every manuscript undergoes double-blind peer review. Accepted articles are open access under CC-BY 4.0 with authors retaining copyright, receive a permanent Crossref DOI, and are discoverable via OpenAlex, Google Scholar, and an OAI-PMH endpoint. The journal follows COPE ethical principles.

Advances fundamental and applied research across the life sciences and bioengineering. As a dedicated biosciences and bioengineering journal, JOBB connects investigators working at the interface of biology and engineering, providing an internationally accessible platform for rigorous, original scholarship that informs research, education, and industrial practice. The journal welcomes work spanning molecular biology and gene engineering (PCR cloning, plasmid vectors, recombinant protein expression), microbial and industrial biotechnology (fermentation, bioactive metabolites, enzyme technology), plant biotechnology and molecular pharming, proteomics, genomics, bioinformatics, and systems biology. We also publish environmental biotechnology, biochemical and bioprocess engineering, and cell and tissue engineering studies that address real-world translational challenges. JOBB serves academic researchers, graduate students, biotechnologists, and industry scientists. We accept original research articles, reviews, methods papers, case reports, and editorials. Every submission undergoes double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence, with authors retaining copyright, and each receives a permanent Crossref DOI. Content is discoverable via OpenAlex, Google Scholar, and an OAI-PMH endpoint, and the journal follows COPE ethical principles.

Dedicated to applied nanoscience at the interface of nanomaterials, nanomedicine and nanotechnology. The journal reports rigorous, original work that translates nanoscale phenomena into practical advances for health, engineering and the life sciences, with particular strength in nanoparticle-based drug delivery, nano-oncology and radiotherapy enhancement, nanodiagnostics and biosensing. We welcome original research, reviews, methodological papers, case reports and editorials spanning nanoparticle synthesis and characterization, functional and theranostic nanomaterials, high-Z nanoparticles for tumor treatment, Monte Carlo dose modeling, circulating-biomarker detection, and nanotoxicology and biocompatibility. Submissions addressing both fundamental mechanisms and applied, translational outcomes are encouraged. Intended for materials scientists, biomedical engineers, pharmaceutical researchers, oncology and imaging specialists, and nanotechnology practitioners, JOAN connects investigators worldwide through a trusted, internationally accessible platform. Every submission undergoes double-blind peer review; accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) license with authors retaining copyright, assigned a permanent Crossref DOI, and made discoverable through OpenAlex, Google Scholar and an OAI-PMH endpoint. The journal follows COPE ethical principles.

Publishes original research, reviews, and case reports spanning clinical and medical genetics, genomics, population and evolutionary genetics, and the functional analysis of human genetic variation. The journal serves geneticists, genetic counsellors, clinician-scientists, bioinformaticians, and translational researchers seeking a globally accessible venue for rigorous genetics scholarship. Core topics include genome-wide association studies (GWAS) and SNP disease-susceptibility analysis, structural and copy-number variation detected by optical genome mapping and whole-genome sequencing, rare disease and congenital malformation genetics, variant interpretation and ACMG classification, gene regulation and enhancer-promoter interactions, and population genetics across diverse and underrepresented cohorts including African populations. WJOHG welcomes methodological work, meta-analyses, polygenic risk modelling, and molecular epidemiology studies. Every submission undergoes double-blind peer review, and accepted articles are published open access under a Creative Commons CC-BY 4.0 licence with authors retaining copyright. Each article receives a permanent Crossref DOI and is made discoverable through OpenAlex, Google Scholar, and an OAI-PMH endpoint, ensuring long-term citability and global reach. The journal follows COPE ethical principles and applies article-processing charges on acceptance, with waivers and discounts available.